Evaluation of the Effect of Wet Cupping (Hijama) on Primary Fibromyalgia

Launched by RASMIA ELGOHARY · Mar 16, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a treatment called wet cupping therapy combined with home-based exercise to see if it helps improve symptoms in women with primary fibromyalgia. Fibromyalgia is a long-term condition that causes widespread pain and can make everyday life challenging. The researchers want to find out if adding wet cupping to regular exercise can provide better relief from pain compared to just doing exercise alone.

To participate in this study, women aged 18 to 55 who have been diagnosed with primary fibromyalgia and experience moderate pain are eligible. Participants should not have used certain medications, like muscle relaxants or antidepressants, in the past year. If you join the study, you can expect to undergo wet cupping therapy alongside your exercise routine, and you'll be involved in a supportive environment that aims to help improve your quality of life.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Adult patients aged 18-55 years.
• • Female individuals to avoid the gender confounding factor.
• • Clinical diagnosis of primary fibromyalgia according to the 2016 American College of Rheumatology (ACR) updated diagnostic criteria.
• • Moderate pain intensity of ≥ 45 mm or higher on a visual analog scale (VAS).
• • No use of skeletal muscle relaxants, antidepressants, antiepileptic drugs, corticosteroids, benzodiazepines, and tramadol within a year before the screening visit.
• Exclusion Criteria:
• • Underlying rheumatic, malignant, metabolic, hematological, or neurological disorders.
• • Patients with bleeding disorders or receiving anticoagulants.
• • Previous use, within a year, or current use of skeletal muscle relaxants, antidepressants, antiepileptic drugs, corticosteroids, benzodiazepines, or tramadol
• • Patients with BMI ≤ 18 or ≥ 35.
• • Pregnant or lactating women.
• • Patients with severe anemia.